Profuse oral secretions after propafenone administration in neonates

Fiammetta Piersigilli; Cinzia Auriti; Massimo Stefano Silvetti; Gabriella Marrocco; Fabrizio Drago; Giulio Seganti

doi:10.1016/j.jpeds.2010.06.028

Profuse oral secretions after propafenone administration in neonates

Fiammetta Piersigilli, Cinzia Auriti, Massimo Stefano Silvetti, Gabriella Marrocco, Fabrizio Drago, Giulio Seganti

Ospedale Pediatrico Bambino Gesu

Research output: Contribution to journal › Article › peer-review

Abstract

Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. We describe a previously unreported adverse effect in 3 newborns: oral propafenone-induced profuse oral secretions and respiratory distress of sufficient severity to necessitate discontinuation of propafenone.

Original language	English
Pages (from-to)	856-857
Number of pages	2
Journal	Journal of Pediatrics
Volume	157
Issue number	5
DOIs	https://doi.org/10.1016/j.jpeds.2010.06.028
Publication status	Published - Nov 2010

Keywords

ECG
Electrocardiogram
Supraventricular tachycardia
SVT

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Medicine(all)

Access to Document

10.1016/j.jpeds.2010.06.028

Fingerprint Dive into the research topics of 'Profuse oral secretions after propafenone administration in neonates'. Together they form a unique fingerprint.

Cite this

@article{84a2487091454cd38e90bbae4680b3b3,

title = "Profuse oral secretions after propafenone administration in neonates",

abstract = "Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. We describe a previously unreported adverse effect in 3 newborns: oral propafenone-induced profuse oral secretions and respiratory distress of sufficient severity to necessitate discontinuation of propafenone.",

keywords = "ECG, Electrocardiogram, Supraventricular tachycardia, SVT",

author = "Fiammetta Piersigilli and Cinzia Auriti and Silvetti, {Massimo Stefano} and Gabriella Marrocco and Fabrizio Drago and Giulio Seganti",

year = "2010",

month = nov,

doi = "10.1016/j.jpeds.2010.06.028",

language = "English",

volume = "157",

pages = "856--857",

journal = "Journal of Pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Profuse oral secretions after propafenone administration in neonates

AU - Piersigilli, Fiammetta

AU - Auriti, Cinzia

AU - Silvetti, Massimo Stefano

AU - Marrocco, Gabriella

AU - Drago, Fabrizio

AU - Seganti, Giulio

PY - 2010/11

Y1 - 2010/11

N2 - Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. We describe a previously unreported adverse effect in 3 newborns: oral propafenone-induced profuse oral secretions and respiratory distress of sufficient severity to necessitate discontinuation of propafenone.

AB - Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. We describe a previously unreported adverse effect in 3 newborns: oral propafenone-induced profuse oral secretions and respiratory distress of sufficient severity to necessitate discontinuation of propafenone.

KW - ECG

KW - Electrocardiogram

KW - Supraventricular tachycardia

KW - SVT

UR - http://www.scopus.com/inward/record.url?scp=77958065708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958065708&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2010.06.028

DO - 10.1016/j.jpeds.2010.06.028

M3 - Article

C2 - 20659741

AN - SCOPUS:77958065708

VL - 157

SP - 856

EP - 857

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 5

ER -